Cargando…
Exploring Cytotoxic mRNAs as a Novel Class of Anti-cancer Biotherapeutics
New treatments to overcome the obstacles of conventional anti-cancer therapy are a permanent subject of investigation. One promising approach is the application of toxins linked to cell-specific ligands, so-called immunotoxins. Another attractive option is the employment of toxin-encoding plasmids....
Autores principales: | Hirschberger, Kristin, Jarzebinska, Anita, Kessel, Eva, Kretzschmann, Verena, Aneja, Manish K., Dohmen, Christian, Herrmann-Janson, Annika, Wagner, Ernst, Plank, Christian, Rudolph, Carsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908148/ https://www.ncbi.nlm.nih.gov/pubmed/29687033 http://dx.doi.org/10.1016/j.omtm.2017.12.006 |
Ejemplares similares
-
Translation of Angiotensin-Converting Enzyme 2 upon Liver- and Lung-Targeted Delivery of Optimized Chemically Modified mRNA
por: Schrom, Eva, et al.
Publicado: (2017) -
Segmented poly(A) tails significantly reduce recombination of plasmid DNA without affecting mRNA translation efficiency or half-life
por: Trepotec, Zeljka, et al.
Publicado: (2019) -
Human cellular CYBA UTR sequences increase mRNA translation without affecting the half-life of recombinant RNA transcripts
por: Ferizi, Mehrije, et al.
Publicado: (2016) -
Alternative oxidase encoded by sequence-optimized and chemically-modified RNA transfected into mammalian cells is catalytically active
por: Giordano, Luca, et al.
Publicado: (2021) -
Advances in the Development of Biotherapeutics
por: Oliveira, Pedro H., et al.
Publicado: (2015)